Small Molecule CMO/CDMO Global Market Report 2025

Global Small Molecule CMO or CDMO Market Report 2024

Small Molecule CMO/CDMO Global Market Report 2025 – By Product (Small Molecule Drug Product, Small Molecule API), By Stage Type (Clinical, Commercial, Preclinical), By Therapeutic Area (Oncology, Neurology, Infectious Disease, Cardiovascular Disease, Respiratory Disorders, Metabolic Disorders, Other Therapeutics), By Application (Cardiovascular, Oncology, Diabetes, Immunological Disorders) – Market Size, Trends, And Global Forecast 2025-2034

Name: Small Molecule CMO/CDMO Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Small Molecule CMO/CDMO Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Small Molecule CMO/CDMO Global Market Report 2025

Proud Members Of

Small Molecule CMO/CDMO Market Definition

A small-molecule contract manufacturing organization (CMO) or contract development and manufacturing organization (CDMO) is an entity that provides services to other companies in the pharmaceutical industry on a contract basis for the completion of projects and subsequent regulatory submission. These organizations offer a range of services, including contract development, manufacturing, and packaging of small-molecule drugs.

The main types of small-molecule CMO and CDMO are small-molecule drug products and small-molecule (API). A small-molecule drug product refers to the final form of a medicinal product that contains an active pharmaceutical ingredient (API) composed of small molecules. It involves various stages, such as clinical, commercial, and preclinical, IT is used in oncology, neurology, infectious disease, cardiovascular disease, respiratory disorders, metabolic disorders and others and the end users are cardiovascular, oncology, diabetes and immunological disorders.

Small Molecule CMO/CDMO Market Segmentation

The small molecule CMO/CDMO market covered in this report is segmented –

1) By Product: Small Molecule Drug Product, small molecule api

2) By Stage Type: Clinical, Commercial, Preclinical

3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Cardiovascular Disease, Respiratory Disorders, Metabolic Disorders, Other Therapeutics

4) By Application: Cardiovascular, Oncology, Diabetes, Immunological Disorders

Subsegments:

1) By Small Molecule Drug Product: Solid Dosage Forms (Tablets, Capsules), Liquid Dosage Forms (Injectables, Solutions), Topical Dosage Forms

2) By Small Molecule API (Active Pharmaceutical Ingredient): Generic APIs, Branded APIs, Custom Synthesis APIs

Small Molecule CMO/CDMO Market Size and growth rate 2025 to 2029: Graph

Small Molecule CMO/CDMO Market Size 2025 And Growth Rate

The small molecule CMO/CDMO market size has grown strongly in recent years. It will grow from $50.58 billion in 2024 to $54.58 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to favorable government support, cost-effective solutions, growing complexity in drug development, industry consolidation, focus on core competencies.

Small Molecule CMO/CDMO Market Growth Forecast

The small molecule CMO/CDMO market size is expected to see strong growth in the next few years. It will grow to $73.3 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to rise in drug pipelines, globalization of pharmaceutical operations, demand for flexible manufacturing, regulatory compliance expertise, biopharmaceutical convergence. Major trends in the forecast period include sustainable and green manufacturing practices, increased collaboration and partnerships, personalized medicine and niche therapies, rise in virtual and virtual-to-reality companies, integration of digital technologies, rapid response manufacturing.

Book your 30 minutes free consultation with our research experts

Small Molecule CMO/CDMO Market Driver: Surge in Pharmaceutical Demand Propels Growth Of Small-Molecule CMO/CDMO Market

The rising demand for pharmaceuticals is expected to propel the growth of the small-molecule CMO/CDMO market going forward. The pharmaceutical industry is a sector that involves the discovery, development, and production of drugs and medicines by both governmental and private entities. Small-molecule CMO/CDMO is used in the pharmaceutical industry to outsource various services, including the development, manufacturing, and packaging of small-molecule drugs, allowing pharmaceutical companies to reduce costs, save time, and streamline processes. For instance, in August 2024, according to the Government of Canada, a Canada-based government agency, domestic exports in the pharmaceutical sector rose to 9.59 billion USD (12.79 billion CAD) in 2022, up from 10.71 billion CAD in 2021. Imports also increased, reaching 30.21 billion CAD compared to 26.63 billion CAD in 2021. Therefore, the rising demand for pharmaceuticals is driving the growth of the small-molecule CMO/CDMO market.

Global Small Molecule CMO/CDMO Market Major Players

Major companies operating in the small molecule CMO/CDMO market report are Patheon NV (Thermo Fisher Scientific), GlaxoSmithKline, Johnson Matthey PLC, Lonza Group Ltd., WuXi AppTec, Catalent Inc., Aurobindo Pharma, Fareva, Aesica Pharmaceuticals Limited, Siegfried holdings AG, Recipharm AB, Jubilant Life Sciences Limited, Almac Group, Piramal Pharma Solutions, Oxford Chemicals Inc., Syngene International Limited, Novasep, Pfizer CentreOne, GVK Biosciences, ChemPartner, Avid Bioservices Inc., Dishman Carbogen Amcis Ltd., ProChem Inc., Metrics Contract Services

Global Small Molecule CMO/CDMO Market Trend: Industry Benchmark With Innovative Small-Molecule Platform

Major companies operating in the small-molecule CMO/CDMO market are focusing on innovative technologies, such as the state-of-the-art small-molecule platform in Shanghai, to elevate CDMO services. The state-of-the-art small-molecule platform represents the forefront of technological innovations to develop and produce small-molecule drugs and to create safer, more effective, and more efficiently produced pharmaceutical compounds. For instance, in June 2023, Porton Pharma Solutions Ltd., a China-based pharmaceutical company, launched a state-of-the-art small-molecule platform in Shanghai, elevating CDMO services. A state-of-the-art small molecule platform embodies a holistic approach, combining cutting-edge technologies and methodologies to advance the entire lifecycle of small molecule pharmaceuticals and one-stop-shop solutions, an end-to-end platform, flexibility and availability, and digital transformation.

Small Molecule CMO/CDMO Market Merger And Acquisition: Catalent Inc. And Grünenthal GmbH Forge Strategic Partnership to Accelerate Small Molecule Clinical Development

In March 2023, Catalent Inc., a US-based pharmaceutical company, partnered with Grünentha GmbH. This partnership aims to facilitate expedited clinical development timelines for an orally dosed small molecule in Grünenthal's pipeline, improve the bioavailability of the small molecule, and reduce the Phase 1 development timeline. Grunentha GmbH is a Germany-based pharmaceutical company involved in partnerships and agreements with contract development and manufacturing organizations (CDMOs).

Regional Outlook For The Global Small Molecule CMO/CDMO Market

North America was the largest region in the small molecule CMO/CDMO market in 2024. The regions covered in the small molecule CMO/CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the small-molecule contract manufacturing organization (CMO) or contract development and manufacturing organization (CDMO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Small Molecule CMO/CDMO Market?

The small-molecule contract manufacturing organization (CMO) or contract development and manufacturing organization (CDMO) market consists of revenues earned by entities by providing services such as drug development services, process scale-up, quality control and testing, technology transfer, and clinical trial support. The market value includes the value of related goods sold by the service provider or included within the service offering. The small-molecule contract manufacturing organization (CMO) or contract development and manufacturing organization (CDMO) market also includes sales of active pharmaceutical ingredients, drug intermediates, and drug formulation. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Small Molecule CMO/CDMO Industry?

The small-molecule CMO/CDMO market research report is one of a series of new reports from The Business Research Company that provides small-molecule CMO/CDMO market statistics, including small-molecule CMO/CDMO industry global market size, regional shares, competitors with a small-molecule CMO/CDMO market share, detailed small-molecule CMO/CDMO market segments, market trends and opportunities, and any further data you may need to thrive in the small-molecule CMO/CDMO industry. This small-molecule CMO/CDMO market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Small Molecule CMO/CDMO Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$54.58 billion
Revenue Forecast In 2034	$73.3 billion
Growth Rate	CAGR of 7.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Product: Small Molecule Drug Product, Small Molecule API 2) By Stage Type: Clinical, Commercial, Preclinical 3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Cardiovascular Disease, Respiratory Disorders, Metabolic Disorders, Other Therapeutics 4) By Application: Cardiovascular, Oncology, Diabetes, Immunological Disorders Subsegments: 1) By Small Molecule Drug Product: Solid Dosage Forms (Tablets, Capsules), Liquid Dosage Forms (Injectables, Solutions), Topical Dosage Forms 2) By Small Molecule API (Active Pharmaceutical Ingredient): Generic APIs, Branded APIs, Custom Synthesis APIs
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Patheon NV (Thermo Fisher Scientific), GlaxoSmithKline, Johnson Matthey plc, Lonza Group Ltd., WuXi AppTec, Catalent Inc., Aurobindo Pharma, Fareva, Aesica Pharmaceuticals Limited, Siegfried holdings AG, Recipharm AB, Jubilant Life Sciences Limited, Almac Group, Piramal Pharma Solutions, Oxford Chemicals Inc., Syngene International Limited, Novasep, Pfizer CentreOne, GVK Biosciences, ChemPartner, Avid Bioservices Inc., Dishman Carbogen Amcis Ltd, ProChem Inc., Metrics Contract Services
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Small Molecule CMO/CDMO Market Characteristics

3. Small Molecule CMO/CDMO Market Trends And Strategies

4. Small Molecule CMO/CDMO Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Small Molecule CMO/CDMO Growth Analysis And Strategic Analysis Framework

5.1. Global Small Molecule CMO/CDMO PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Small Molecule CMO/CDMO Market Growth Rate Analysis

5.4. Global Small Molecule CMO/CDMO Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Small Molecule CMO/CDMO Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Small Molecule CMO/CDMO Total Addressable Market (TAM)

6. Small Molecule CMO/CDMO Market Segmentation

6.1. Global Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Small Molecule Drug Product

Small Molecule API

6.2. Global Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical

Commercial

Preclinical

6.3. Global Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Neurology

Infectious Disease

Cardiovascular Disease

Respiratory Disorders

Metabolic Disorders

Other Therapeutics

6.4. Global Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cardiovascular

Oncology

Diabetes

Immunological Disorders

6.5. Global Small Molecule CMO/CDMO Market, Sub-Segmentation Of Small Molecule Drug Product, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Solid Dosage Forms (Tablets, Capsules)

Liquid Dosage Forms (Injectables, Solutions)

Topical Dosage Forms

6.6. Global Small Molecule CMO/CDMO Market, Sub-Segmentation Of Small Molecule API (Active Pharmaceutical Ingredient), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Generic APIs

Branded APIs

Custom Synthesis APIs

7. Small Molecule CMO/CDMO Market Regional And Country Analysis

7.1. Global Small Molecule CMO/CDMO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Small Molecule CMO/CDMO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Small Molecule CMO/CDMO Market

8.1. Asia-Pacific Small Molecule CMO/CDMO Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Small Molecule CMO/CDMO Market

9.1. China Small Molecule CMO/CDMO Market Overview

9.2. China Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Small Molecule CMO/CDMO Market

10.1. India Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Small Molecule CMO/CDMO Market

11.1. Japan Small Molecule CMO/CDMO Market Overview

11.2. Japan Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Small Molecule CMO/CDMO Market

12.1. Australia Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Small Molecule CMO/CDMO Market

13.1. Indonesia Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Small Molecule CMO/CDMO Market

14.1. South Korea Small Molecule CMO/CDMO Market Overview

14.2. South Korea Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Small Molecule CMO/CDMO Market

15.1. Western Europe Small Molecule CMO/CDMO Market Overview

15.2. Western Europe Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Small Molecule CMO/CDMO Market

16.1. UK Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Small Molecule CMO/CDMO Market

17.1. Germany Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Small Molecule CMO/CDMO Market

18.1. France Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Small Molecule CMO/CDMO Market

19.1. Italy Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Small Molecule CMO/CDMO Market

20.1. Spain Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Small Molecule CMO/CDMO Market

21.1. Eastern Europe Small Molecule CMO/CDMO Market Overview

21.2. Eastern Europe Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Small Molecule CMO/CDMO Market

22.1. Russia Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Small Molecule CMO/CDMO Market

23.1. North America Small Molecule CMO/CDMO Market Overview

23.2. North America Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Small Molecule CMO/CDMO Market

24.1. USA Small Molecule CMO/CDMO Market Overview

24.2. USA Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Small Molecule CMO/CDMO Market

25.1. Canada Small Molecule CMO/CDMO Market Overview

25.2. Canada Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Small Molecule CMO/CDMO Market

26.1. South America Small Molecule CMO/CDMO Market Overview

26.2. South America Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Small Molecule CMO/CDMO Market

27.1. Brazil Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Small Molecule CMO/CDMO Market

28.1. Middle East Small Molecule CMO/CDMO Market Overview

28.2. Middle East Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Small Molecule CMO/CDMO Market

29.1. Africa Small Molecule CMO/CDMO Market Overview

29.2. Africa Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Small Molecule CMO/CDMO Market Competitive Landscape And Company Profiles

30.1. Small Molecule CMO/CDMO Market Competitive Landscape

30.2. Small Molecule CMO/CDMO Market Company Profiles

30.2.1. Patheon NV (Thermo Fisher Scientific) Overview, Products and Services, Strategy and Financial Analysis

30.2.2. GlaxoSmithKline Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Johnson Matthey plc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Lonza Group Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. WuXi AppTec Overview, Products and Services, Strategy and Financial Analysis

31. Small Molecule CMO/CDMO Market Other Major And Innovative Companies

31.1. Catalent Inc.

31.2. Aurobindo Pharma

31.3. Fareva

31.4. Aesica Pharmaceuticals Limited

31.5. Siegfried holdings AG

31.6. Recipharm AB

31.7. Jubilant Life Sciences Limited

31.8. Almac Group

31.9. Piramal Pharma Solutions

31.10. Oxford Chemicals Inc.

31.11. Syngene International Limited

31.12. Novasep

31.13. Pfizer CentreOne

31.14. GVK Biosciences

31.15. ChemPartner

32. Global Small Molecule CMO/CDMO Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Small Molecule CMO/CDMO Market

34. Recent Developments In The Small Molecule CMO/CDMO Market

35. Small Molecule CMO/CDMO Market High Potential Countries, Segments and Strategies

35.1 Small Molecule CMO/CDMO Market In 2029 - Countries Offering Most New Opportunities

35.2 Small Molecule CMO/CDMO Market In 2029 - Segments Offering Most New Opportunities

35.3 Small Molecule CMO/CDMO Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Small Molecule CMO/CDMO Market, Sub-Segmentation Of Small Molecule Drug Product, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Small Molecule CMO/CDMO Market, Sub-Segmentation Of Small Molecule API (Active Pharmaceutical Ingredient), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Small Molecule CMO/CDMO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Small Molecule CMO/CDMO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Patheon NV (Thermo Fisher Scientific) Financial Performance

Table 78: GlaxoSmithKline Financial Performance

Table 79: Johnson Matthey plc Financial Performance

Table 80: Lonza Group Ltd. Financial Performance

Table 81: WuXi AppTec Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Small Molecule CMO/CDMO Market, Sub-Segmentation Of Small Molecule Drug Product, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Small Molecule CMO/CDMO Market, Sub-Segmentation Of Small Molecule API (Active Pharmaceutical Ingredient), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Small Molecule CMO/CDMO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Small Molecule CMO/CDMO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Patheon NV (Thermo Fisher Scientific) Financial Performance

Figure 78: GlaxoSmithKline Financial Performance

Figure 79: Johnson Matthey plc Financial Performance

Figure 80: Lonza Group Ltd. Financial Performance

Figure 81: WuXi AppTec Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multivitamin capsules and tablets market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the dry eye medication market research report 2022 with industry size, share, segments and market growth

Non-Therapeutic Biomolecules Global Market Report 2025 – By Trad Pharma( Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies), By End User( Research, Pharma, In vitro diagnostics(IVD)) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Small Molecule API Global Market Report 2025 – By Type( Synthetic, Biotech), By Manufacturer( In-House, Outsourced), By Application( Cardiology, Oncology, CNS And Neurology, Orthopedic, Endocrinology, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Small Molecule Drug Discovery Global Market Report 2025 – By Drug Type (Small Molecule Drugs, Biologic Drugs), By Technology (High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others), By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others), By Process/Phase (Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization), By End-User (Pharmaceutical Companies, Contract Research Organizations, Others) – Market Size, Trends, And Global Forecast 2025-2034

View Report

RNA Targeting Small Molecules Therapeutics Global Market Report 2025 – By Offering (mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Targeting, Other Offerings), By Therapeutic Indication (Lung Fibrosis, Cancer, Neurodegenerative Diseases, Autoimmune, Inflammatory, Other Therapeutic Indications), By Application (Drug Discovery, Oncology Research, Disease Identification), By End User (Hospitals, Research Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Small Molecule Innovator CDMO Global Market Report 2025 – By Product (Small Molecule Active Pharmaceutical Ingredient (API), Small Molecule Drug Product), By Stage (Preclinical, Clinical, Commercial), By Therapeutic (Cardiovascular Disease, Oncology, Respiratory Disorders, Neurology, Metabolic Disorders, Infectious Disease, Other Therapeutics), By Customer (Pharmaceutical, Biotechnology) – Market Size, Trends, And Global Forecast 2025-2034

View Report

RNA Targeting Small Molecule Drug Discovery Global Market Report 2025 – By Target RNA Type (Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)), By Technology (CRISPR-Cas9, RNA Aptamers, Small Interfering RNA (siRNA), Ribozymes, Other Technologies), By Therapeutic Area (Oncology, Neurology, Infectious Disease, Metabolic Diseases, Genetic Disorders, Other Therapeutic Areas), By Delivery Method (Intravenous (IV), Oral, Topical, Other Methods), By Application (Research Use, Therapeutic Use, Diagnostic Use, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Small Molecule Active Pharmaceutical Ingredient Global Market Report 2025 – By Type (Synthetic, Chemical, Biological), By Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology), By Manufacturing Method (In-House, Contract), By Application (Clinical, Commercial) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hydrogen Aircraft Global Market Report 2025 – By Technology (Fully Hydrogen Powered Aircraft, Hybrid Electric Aircraft, Hydrogen Fuel Cell Aircraft, Liquid Hydrogen Aircraft), By Power Source (Hydrogen Combustion, Hydrogen Fuel Cell), By Range (20 Km To 100 Km, More Than 100 Km, Up To 20 Km), By Platform (Air Taxis, Business Jets, Unmanned Aerial Vehicles) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Small Molecule CMO/CDMO market?

How will the Small Molecule CMO/CDMO market drivers and restraints affect the market dynamics? What forces will shape the Small Molecule CMO/CDMO industry going forward?

The Small Molecule CMO/CDMO market major growth driver - Surge in Pharmaceutical Demand Propels Growth Of Small-Molecule CMO/CDMO Market. For further insights on the Small Molecule CMO/CDMO market, request a sample here

What is the forecast market size or the forecast market value of the Small Molecule CMO/CDMO market?

The Small Molecule CMO/CDMO market size has grown strongly in recent years. The small molecule CMO/CDMO market size has grown strongly in recent years. It will grow from $50.58 billion in 2024 to $54.58 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to favorable government support, cost-effective solutions, growing complexity in drug development, industry consolidation, focus on core competencies. The small molecule CMO/CDMO market size is expected to see strong growth in the next few years. It will grow to $73.3 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to rise in drug pipelines, globalization of pharmaceutical operations, demand for flexible manufacturing, regulatory compliance expertise, biopharmaceutical convergence. Major trends in the forecast period include sustainable and green manufacturing practices, increased collaboration and partnerships, personalized medicine and niche therapies, rise in virtual and virtual-to-reality companies, integration of digital technologies, rapid response manufacturing. For further insights on the Small Molecule CMO/CDMO market, request a sample here

How is the Small Molecule CMO/CDMO market segmented?

The small molecule CMO/CDMO market covered in this report is segmented –
1) By Product: Small Molecule Drug Product, Small Molecule API
2) By Stage Type: Clinical, Commercial, Preclinical
3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Cardiovascular Disease, Respiratory Disorders, Metabolic Disorders, Other Therapeutics
4) By Application: Cardiovascular, Oncology, Diabetes, Immunological Disorders Subsegments:
1) By Small Molecule Drug Product: Solid Dosage Forms (Tablets, Capsules), Liquid Dosage Forms (Injectables, Solutions), Topical Dosage Forms
2) By Small Molecule API (Active Pharmaceutical Ingredient): Generic APIs, Branded APIs, Custom Synthesis APIs For further insights on the Small Molecule CMO/CDMO market, request a sample here

Which region has the largest share of the Small Molecule CMO/CDMO market? What are the other regions covered in the report?

North America was the largest region in the small molecule CMO/CDMO market in 2024. The regions covered in the small molecule CMO/CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Small Molecule CMO/CDMO market, request a sample here.

Who are the major players in the Small Molecule CMO/CDMO market?

What are the key trends in the Small Molecule CMO/CDMO market?

Major trends in the Small Molecule CMO/CDMO market include Industry Benchmark With Innovative Small-Molecule Platform. For further insights on the Small Molecule CMO/CDMO market, request a sample here.

What are the major opportunities in the Small Molecule CMO/CDMO market? What are the strategies for the Small Molecule CMO/CDMO market?

For detailed insights on the major opportunities and strategies in the Small Molecule CMO/CDMO market, request a sample here.

How does the Small Molecule CMO/CDMO market relate to the overall economy and other similar markets?

For detailed insights on Small Molecule CMO/CDMO's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Small Molecule CMO/CDMO industry?

For detailed insights on the mergers and acquisitions in the Small Molecule CMO/CDMO industry, request a sample here.

What are the key dynamics influencing the Small Molecule CMO/CDMO market growth? SWOT analysis of the Small Molecule CMO/CDMO market.

For detailed insights on the key dynamics influencing the Small Molecule CMO/CDMO market growth and SWOT analysis of the Small Molecule CMO/CDMO industry, request a sample here.